Alcohol and cannabis consumption in patients with inflammatory bowel disease: Prevalence, pattern of consumption and impact on the disease
European Journal of Gastroenterology and Hepatology, ISSN: 1473-5687, Vol: 35, Issue: 1, Page: 21-30
2023
- 7Citations
- 10Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations7
- Citation Indexes7
- CrossRef7
- Captures10
- Readers10
- 10
- Mentions1
- News Mentions1
- News1
Most Recent News
New Marijuana/Cannabis Study Findings Have Been Reported by Investigators at Bern University Hospital (Alcohol and Cannabis Consumption In Patients With Inflammatory Bowel Disease: Prevalence, Pattern of Consumption and Impact On the Disease)
2023 MAR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Marijuana Daily -- Fresh data on Marijuana/Cannabis are presented in a new report.
Article Description
Objectives of the study There is little guidance regarding the impact of alcohol and cannabis on the clinical course of inflammatory bowel disease. The aim of this study was to assess the prevalence, sociodemographic characteristics and impact of alcohol and cannabis use on the clinical course of the disease. Methods We performed an analysis of prospectively collected data within the Swiss Inflammatory Bowel Disease Cohort Study with yearly follow-ups and substance-specific questionnaires. We analyzed the prevalence of use, the profile of users at risk for addiction and the impact of alcohol and cannabis on the course of the disease. Results We collected data of 2828 patients included between 2006 and 2018 and analyzed it according to their completion of specific surveys on alcohol and cannabis use. The prevalence of patient-reported active use was 41.3% for alcohol and 6% for cannabis. Heavy drinkers were over-represented among retired, married smokers receiving mostly aminosalicylates and less immunosuppression. In ulcerative colitis patients, low-to-moderate drinking was associated with less extensive disease. Cannabis users were often students with ileal Crohn's disease. Conclusion A significant proportion of patients with inflammatory bowel disease consume alcohol or cannabis. Heavy alcohol consumption is most likely in male smokers >50 years, whereas young men with ileal disease rather use cannabis.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85143379961&origin=inward; http://dx.doi.org/10.1097/meg.0000000000002453; http://www.ncbi.nlm.nih.gov/pubmed/36317770; https://journals.lww.com/10.1097/MEG.0000000000002453; https://dx.doi.org/10.1097/meg.0000000000002453; https://journals.lww.com/eurojgh/fulltext/2023/01000/alcohol_and_cannabis_consumption_in_patients_with.3.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know